Literature DB >> 11751940

Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease.

Tetsuya Higuchi1, Yuichi Aiba, Takashi Nomura, Junichiro Matsuda, Keiji Mochida, Misao Suzuki, Hitoshi Kikutani, Tasuku Honjo, Kiyoshi Nishioka, Takeshi Tsubata.   

Abstract

CD40 ligand (CD40L) is ectopically expressed on B cells in patients with systemic lupus erythematosus (SLE) and lupus-prone BXSB mice. To assess the role of the ectopic CD40L expression in development of SLE, we have established transgenic mice expressing CD40L on B cells. Some of the 12- to 14-mo-old CD40L-transgenic mice spontaneously produced autoantibodies such as antinuclear Abs, anti-DNA Abs, and antihistone Abs. Moreover, approximately half of the transgenic mice developed glomerulonephritis with immune-complex deposition, whereas the kidneys of the normal littermates showed either no pathological findings or only mild histological changes. These results indicate that CD40L on B cells causes lupus-like disease in the presence of yet unknown environmental factors that by themselves do not induce the disease. Thus, ectopic CD40L expression on B cells may play a crucial role in development of SLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751940     DOI: 10.4049/jimmunol.168.1.9

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

1.  Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus.

Authors:  Faith M Strickland; Anura Hewagama; Qianjian Lu; Ailing Wu; Robert Hinderer; Ryan Webb; Kent Johnson; Amr H Sawalha; Colin Delaney; Raymond Yung; Bruce C Richardson
Journal:  J Autoimmun       Date:  2011-12-03       Impact factor: 7.094

Review 2.  Targeting CD40L: a promising therapeutic approach.

Authors:  Dimitris Daoussis; Andrew P Andonopoulos; Stamatis-Nick C Liossis
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

3.  Comparative analysis of signal transduction by CD40 and the Epstein-Barr virus oncoprotein LMP1 in vivo.

Authors:  Dimitris Panagopoulos; Panayiotis Victoratos; Maria Alexiou; George Kollias; George Mosialos
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 4.  Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity.

Authors:  Di Yu; Carola G Vinuesa
Journal:  Cell Mol Immunol       Date:  2010-04-05       Impact factor: 11.530

5.  Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas.

Authors:  Anna Bolduc; Eugene Long; Dale Stapler; Marilia Cascalho; Takeshi Tsubata; Pandelakis A Koni; Michiko Shimoda
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 6.  Genetics of SLE in mice.

Authors:  Dwight H Kono; Argyrios N Theofilopoulos
Journal:  Springer Semin Immunopathol       Date:  2006-09-14

Review 7.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

8.  Insulin-like growth factor-2 enhances functions of antigen (Ag)-specific regulatory B cells.

Authors:  Xiao-Rui Geng; Gui Yang; Meng Li; Jiang-Ping Song; Zhi-Qiang Liu; Shuqi Qiu; Zhigang Liu; Ping-Chang Yang
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

9.  B cells from African American lupus patients exhibit an activated phenotype.

Authors:  Laurence C Menard; Sium Habte; Waldemar Gonsiorek; Deborah Lee; Dana Banas; Deborah A Holloway; Nataly Manjarrez-Orduno; Mark Cunningham; Dawn Stetsko; Francesca Casano; Selena Kansal; Patricia M Davis; Julie Carman; Clarence K Zhang; Ferva Abidi; Richard Furie; Steven G Nadler; Suzanne J Suchard
Journal:  JCI Insight       Date:  2016-06-16

Review 10.  B-cell-targeted therapies in systemic lupus erythematosus.

Authors:  Vera Sau-Fong Chan; Helen Hoi-Lun Tsang; Rachel Chun-Yee Tam; Liwei Lu; Chak-Sing Lau
Journal:  Cell Mol Immunol       Date:  2013-01-28       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.